Literature DB >> 16257122

Hyperglycemia increases superoxide production in the CA1 pyramidal neurons after global cerebral ischemia.

Marianna Muranyi1, Ping-An Li.   

Abstract

Transient global cerebral ischemia results in selective neuronal death in the vulnerable hippocampal CA1 pyramidal neurons in a delayed manner. Hyperglycemia accelerates and exacerbates neuronal damage in this region. The object of this study was to determine whether hyperglycemia-enhanced damage is associated with increased production of superoxide anion after ischemia. The results showed that hyperglycemic ischemia caused a significant increase of superoxide production in the hippocampal CA1 neurons compared to normoglycemic animals after 18 h of recirculation, suggesting that enhanced superoxide anion production may mediate the hyperglycemia-accelerated and -enhanced neuronal death in the hippocampal CA1 area after ischemia and reperfusion.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16257122     DOI: 10.1016/j.neulet.2005.09.079

Source DB:  PubMed          Journal:  Neurosci Lett        ISSN: 0304-3940            Impact factor:   3.046


  11 in total

1.  Hyperglycemia promotes tissue plasminogen activator-induced hemorrhage by Increasing superoxide production.

Authors:  Seok Joon Won; Xian Nan Tang; Sang Won Suh; Midori A Yenari; Raymond A Swanson
Journal:  Ann Neurol       Date:  2011-10-14       Impact factor: 10.422

2.  Influence of hyperglycemia on oxidative stress and matrix metalloproteinase-9 activation after focal cerebral ischemia/reperfusion in rats: relation to blood-brain barrier dysfunction.

Authors:  Hiroshi Kamada; Fengshan Yu; Chikako Nito; Pak H Chan
Journal:  Stroke       Date:  2007-02-01       Impact factor: 7.914

3.  Estrogen attenuates ischemic oxidative damage via an estrogen receptor alpha-mediated inhibition of NADPH oxidase activation.

Authors:  Quan-Guang Zhang; Limor Raz; Ruimin Wang; Dong Han; Liesl De Sevilla; Fang Yang; Ratna K Vadlamudi; Darrell W Brann
Journal:  J Neurosci       Date:  2009-11-04       Impact factor: 6.167

4.  Effects of glucose concentration on redox status in rat primary cortical neurons under hypoxia.

Authors:  Honglian Shi; Ke Jian Liu
Journal:  Neurosci Lett       Date:  2006-10-18       Impact factor: 3.046

5.  Monosialotetrahexosy-1 ganglioside attenuates diabetes-enhanced brain damage after transient forebrain ischemia and suppresses phosphorylation of ERK1/2 in the rat brain.

Authors:  Jian-Zhong Zhang; Li Jing; Yi Ma; Feng-Ying Guo; Yue Chang; P Andy Li
Journal:  Brain Res       Date:  2010-06-08       Impact factor: 3.252

6.  Assessment at the single-cell level identifies neuronal glutathione depletion as both a cause and effect of ischemia-reperfusion oxidative stress.

Authors:  Seok Joon Won; Ji-Eun Kim; Giordano Fabricio Cittolin-Santos; Raymond A Swanson
Journal:  J Neurosci       Date:  2015-05-06       Impact factor: 6.167

7.  Acute Hyperglycemia Exacerbates Hemorrhagic Transformation after Embolic Stroke and Reperfusion with tPA: A Possible Role of TXNIP-NLRP3 Inflammasome.

Authors:  Mohd Salman; Saifudeen Ismael; Lexiao Li; Heba A Ahmed; Michelle A Puchowicz; Tauheed Ishrat
Journal:  J Stroke Cerebrovasc Dis       Date:  2021-11-27       Impact factor: 2.136

8.  Overexpression of selenoprotein H reduces Ht22 neuronal cell death after UVB irradiation by preventing superoxide formation.

Authors:  Kamel E Ben Jilani; Jun Panee; Qingping He; Marla J Berry; Ping-An Li
Journal:  Int J Biol Sci       Date:  2007-02-11       Impact factor: 6.580

9.  Inhibition of mTOR signaling Confers Protection against Cerebral Ischemic Injury in Acute Hyperglycemic Rats.

Authors:  Changchun Hei; Ping Liu; Xiao Yang; Jianguo Niu; P Andy Li
Journal:  Int J Biol Sci       Date:  2017-07-07       Impact factor: 6.580

10.  Temporal profile of astrocytes and changes of oligodendrocyte-based myelin following middle cerebral artery occlusion in diabetic and non-diabetic rats.

Authors:  Li Jing; Qingping He; Jian-Zhong Zhang; P Andy Li
Journal:  Int J Biol Sci       Date:  2013-02-11       Impact factor: 6.580

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.